| Cat.#: 28112 |
| Product Name: Anti-IL22(Fezakinumab) Monoclonal Antibody |
| Synonyms: IL-22;Cytokine Zcyto18;IL-TIF |
| Description: Anti-IL22(fezakinumab ) Monoclonal Antibody |
| Background: Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals. |
| Applications: ELISA; Flow Cyt |
| Recommended Dilutions: ELISA 1:5000-10000; Flow Cyt 1:100 |
| Host Species: Homo sapiens |
| Isotype: IgG1 |
| Purification: Purified from cell culture supernatant by affinity chromatography |
| Species Reactivity: Human IL22 |
| Constituents: Lyophilized from sterile PBS, pH 7.4. 5 % – 8% trehalose is added as protectants before lyophilization. |
| Storage & Shipping: Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). |
Figure 1. ELISA plate pre-coated by 2 µg/mL (100 µl/well) Human IL22 Protein, hFc Tag (11447) can bind Anti-IL22 Neutralizing antibody (28112) in a linear range of 2.44-625.00 ng/mL. In order to specifically detect 28112, mouse anti-human Fab-specific antibody was used as detection antibody. | 
Figure 2. Flow cytometry analysis under cell membrane permeable condition with 1 µg/mL Anti-IL22 (fezakinumab biosimilar) mAb (28112) on Expi293 cells transfected with Human IL22 protein (Blue histogram) or Expi293 transfected with irrelevant protein (Red histogram). |
|
